Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic methotrexate after linear salpingostomy: a decision analysis.

C R Gracia1, H A Brown, K T Barnhart

  • 1Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Fertility and Sterility
|December 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-disciplinary heat acclimatization research for climate change resilience.

Journal of applied physiology (Bethesda, Md. : 1985)·2024
Same author

Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.

Contraception·2018
Same author

Obstetrical and perinatal outcomes following blastocyst transfer compared to cleavage transfer: a systematic review and meta-analysis.

Human reproduction (Oxford, England)·2016
Same author

Cost-effectiveness of salpingotomy and salpingectomy in women with tubal pregnancy (a randomized controlled trial).

Human reproduction (Oxford, England)·2015
Same author

Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary.

Human reproduction (Oxford, England)·2013
Same author

Hormone variations associated with quantitative fat measures in the menopausal transition.

Climacteric : the journal of the International Menopause Society·2013
Same journal

More Than Cycles: Rethinking Cancer Surveillance in PMOS.

Fertility and sterility·2026
Same journal

Fresh vs. frozen donor oocytes: which strategy best serves patients in contemporary assisted reproductive technology?

Fertility and sterility·2026
Same journal

From fetal life to adulthood: cardiometabolic health of offspring conceived by assisted reproductive technologies, a systematic review.

Fertility and sterility·2026
Same journal

Uterus-Sparing Laparoscopic Reversal of Complete Non-Puerperal uterine Inversion: A rare Case and Challenging Procedure!

Fertility and sterility·2026
Same journal

Minimally Invasive, Fertility-Sparing Surgical Management of Multiple Bilateral Ovarian Dermoid Cysts.

Fertility and sterility·2026
Same journal

Preconception dietary patterns in association with live birth and pregnancy loss: a couples-based approach.

Fertility and sterility·2026
See all related articles

Prophylactic methotrexate after linear salpingostomy for ectopic pregnancy reduces ruptures and procedures compared to observation. However, observation may be preferred if specific conditions, like lower methotrexate success rates, are met.

Area of Science:

  • Reproductive medicine
  • Gynecologic surgery
  • Pharmacologic interventions

Background:

  • Ectopic pregnancy management following linear salpingostomy presents therapeutic challenges.
  • Current standard of care involves observation and treatment of persistent ectopic pregnancy with methotrexate.
  • Alternative strategies, such as prophylactic methotrexate, warrant investigation.

Purpose of the Study:

  • To compare the efficacy and outcomes of observation versus prophylactic methotrexate in managing women after linear salpingostomy for tubal pregnancy.
  • To evaluate the impact of each strategy on tubal rupture, subsequent procedures, complications, and cost.

Main Methods:

  • Decision analysis modeling hypothetical cases of 1000 women undergoing linear salpingostomy for ectopic pregnancy.

Related Experiment Videos

  • Comparison of two management strategies: observation with delayed methotrexate treatment versus immediate prophylactic methotrexate administration.
  • Outcome measures included rates of tubal rupture, surgical interventions, methotrexate-related complications, and economic costs.

    • Main Results:

    • Prophylactic methotrexate demonstrated a significant reduction in tubal rupture (0.4% vs. 3.7%) and the need for further procedures (1.9% vs. 4.7%) compared to observation.
    • The prophylactic strategy was associated with a lower cost per patient ($67.55 less).
    • However, methotrexate-associated complications were more frequent with prophylaxis (5.5% vs. 0.8%).

    Conclusions:

    • Prophylactic methotrexate is a preferable strategy to observation after linear salpingostomy for ectopic pregnancy under specific clinical conditions.
    • Observation remains the optimal strategy when the persistent ectopic pregnancy rate is below 9%, prophylactic methotrexate success is less than 95%, methotrexate complication rates exceed 18%, or the rupture rate of persistent ectopic pregnancies is below 7.3%.